Literature DB >> 12393271

The effect of chronic fluoxetine treatment on brain corticosteroid receptor mRNA expression and spatial memory in young and aged rats.

Joyce L W Yau1, Carina Hibberd, June Noble, Jonathan R Seckl.   

Abstract

As rats age, a subgroup will show spatial memory impairments, along with decreased corticosteroid receptors (MR and/or GR) in the hippocampus and a hyperactive hypothalamic-pituitary-adrenal axis. In previous work, we have shown that amitriptyline treatment increases hippocampal MR mRNA and improves spatial memory in young rats but had no effect in aged rats. Here, we examine the effect of 1-month treatment with the selective 5-HT re-uptake inhibitor, fluoxetine (10 mg/kg, p.o.) on hippocampal corticosteroid receptor mRNA and spatial memory in young 4-month-old and aged 24-month-old rats. Aged rats were impaired in spatial memory compared to young controls. MR mRNA expression was reduced with ageing in all hippocampal subfields except CA4 (35% decrease in dentate gyrus (DG) and CA2, P<0.05) and GR mRNA was decreased selectively in CA1 (17% decrease, P<0.05). Fluoxetine treatment increased GR mRNA in the hippocampus of young rats (24 and 46% increase in DG and CA3, respectively, P<0.01) but had no effect on hippocampal MR mRNA expression. In contrast, in aged rats, fluoxetine treatment increased hippocampal MR mRNA selectively in CA2 (43% increase, P<0.05), but had no effect on hippocampal GR mRNA. Fluoxetine treatment did not alter watermaze performance in either young or aged rats. It appears that increased hippocampal MR (at least in the CA2 region) which may underlie the enhancement in memory processing in young rats, is insufficient to improve memory in already cognitively impaired aged rats.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12393271     DOI: 10.1016/s0169-328x(02)00418-7

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  6 in total

Review 1.  Increased expression of the anti-apoptotic protein Bcl-xL in the brain is associated with resilience to stress-induced depression-like behavior.

Authors:  Nikolay N Dygalo; Tatyana S Kalinina; Veta V Bulygina; Galina T Shishkina
Journal:  Cell Mol Neurobiol       Date:  2012-01-26       Impact factor: 5.046

2.  The mineralocorticoid receptor agonist, fludrocortisone, differentially inhibits pituitary-adrenal activity in humans with psychotic major depression.

Authors:  Anna Lembke; Rowena Gomez; Lakshika Tenakoon; Jennifer Keller; Gregory Cohen; Gordon H Williams; Fredric B Kraemer; Alan F Schatzberg
Journal:  Psychoneuroendocrinology       Date:  2012-06-21       Impact factor: 4.905

3.  Genome-wide DNA methylation in neonates exposed to maternal depression, anxiety, or SSRI medication during pregnancy.

Authors:  Amy L Non; Alexandra M Binder; Laura D Kubzansky; Karin B Michels
Journal:  Epigenetics       Date:  2014-04-21       Impact factor: 4.528

4.  Distinct Antidepressant-Like and Cognitive Effects of Antidepressants with Different Mechanisms of Action in Middle-Aged Female Mice.

Authors:  Yan Li; Connie Sanchez; Maria Gulinello
Journal:  Int J Neuropsychopharmacol       Date:  2017-06-01       Impact factor: 5.176

Review 5.  iPlasticity: Induced juvenile-like plasticity in the adult brain as a mechanism of antidepressants.

Authors:  Juzoh Umemori; Frederike Winkel; Giuliano Didio; Maria Llach Pou; Eero Castrén
Journal:  Psychiatry Clin Neurosci       Date:  2018-07-11       Impact factor: 5.188

Review 6.  Enteric Microbiota⁻Gut⁻Brain Axis from the Perspective of Nuclear Receptors.

Authors:  Kalina Duszka; Walter Wahli
Journal:  Int J Mol Sci       Date:  2018-07-28       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.